Calendar Agile Therapeutics, Inc.

Equities

AGRX

US00847L3087

Market Closed - OTC Markets 19:59:40 26/04/2024 BST 5-day change 1st Jan Change
0.4 USD 0.00% Intraday chart for Agile Therapeutics, Inc. +5.26% -79.49%

Chart calendar Agile Therapeutics, Inc.

d38b71d6e3b7fc8ce7fc95c5.V4u33W8jCbL-O0-Pjtz8o_Rjrs-b47TCntM-BsPaWHg.HMyPnjx5R8GOUnro5qqE25kV4KXXu9ij-6BmUIuraD40_tG5JRR84bJyIA~299ab14826eb16b213b83148a6a4094b

Upcoming events on Agile Therapeutics, Inc.

08/05/2024 Q1 2024 Earnings Release (Projected)
07/08/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
19/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Agile Therapeutics, Inc.

28/03/2024 12:30 Q4 2023 Earnings Call
28/03/2024 12:05 Q4 2023 Earnings Release
09/11/2023 13:30 Q3 2023 Earnings Call
09/11/2023 13:05 Q3 2023 Earnings Release
13/09/2023 17:30 H.C. Wainwright Global Investment Conference
09/08/2023 13:30 Q2 2023 Earnings Call
09/08/2023 13:05 Q2 2023 Earnings Release
08/06/2023 14:00 Annual General Meeting
11/05/2023 21:30 Q1 2023 Earnings Call
11/05/2023 21:05 Q1 2023 Earnings Release
22/03/2023 20:30 Q4 2022 Earnings Call
22/03/2023 20:05 Q4 2022 Earnings Release
08/03/2023 Extraordinary Shareholder Meeting
05/12/2022 20:20 RHK Capital Disruptive Growth Conference
07/11/2022 21:30 Q3 2022 Earnings Call
07/11/2022 21:05 Q3 2022 Earnings Release
13/09/2022 15:00 H.C. Wainwright Global Investment Conference
11/08/2022 21:30 Interim 2022 Earnings Call
11/08/2022 21:05 Interim 2022 Earnings Release
13/07/2022 16:00 Maxim Group M-Vest Virtual Conference - Panel

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,75
1,01
-25.59%
4,10
4,10
-0.06%
10,9
10,0
8.69%
19,6
20,0
-2.26%
EBITDA
Million USD
Released
Forecast
Spread
-18,7
-17,3
-8.37%
-48,8
-51,1
4.55%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-18,9
-17,5
-7.93%
-49,1
-51,5
4.8%
-71,0
-64,1
-10.75%
-52,6
-48,9
-7.54%
-19,9
-19,0
-4.59%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-18,6
-17,4
-7.1%
-51,9
-54,4
4.6%
-74,9
-68,0
-10.09%
-30,1
-57,4
47.57%
-14,5
-12,7
-13.76%
Net income
Million USD
Released
Forecast
Spread
-18,6
-17,4
-7.1%
-51,9
-54,4
4.6%
-74,9
-68,0
-10.09%
-25,4
-52,7
51.79%
-14,5
-12,7
-13.76%
EPS
USD
Released
Forecast
Spread
-760
-704
-7.95%
-1 220
-1 285
5.06%
-1 540
-1 393
-10.53%
-59,0
-123
52.03%
-6,71
-5,92
-13.34%
Announcement Date20/02/2001/03/2130/03/2222/03/2328/03/24

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
1,51
1,51
0.18%
1,76
1,22
43.87%
2,13
1,98
7.32%
3,00
2,33
28.65%
4,00
3,13
27.87%
3,81
3,40
12.25%
5,50
4,63
18.95%
6,66
6,35
4.87%
3,62
4,07
-11.16%
EBIT
Million USD
Released
Forecast
Spread
-22,4
-17,2
-30.33%
-15,6
-17,5
10.77%
-11,4
-12,3
7.61%
-18,7
-16,7
-12.26%
-6,88
-8,75
21.44%
-6,71
-7,08
5.28%
-5,13
-5,94
13.7%
-4,00
-4,01
0.15%
-4,05
-3,18
-27.48%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-23,4
-18,1
-28.73%
-16,4
-17,9
8.23%
-12,2
-12,9
5.5%
-19,7
-17,2
-14.65%
-3,93
-9,05
56.61%
-5,39
-7,08
23.89%
-3,81
-6,11
37.65%
-0,80
-3,55
77.47%
-4,47
-2,72
-64.41%
Net income
Million USD
Released
Forecast
Spread
-23,4
-18,1
-28.73%
-11,8
-17,9
34.32%
-12,2
-12,9
5.5%
-19,7
-17,2
-14.65%
-3,93
-9,05
56.61%
-5,39
-7,08
23.89%
-3,81
-6,11
37.65%
-0,80
-3,55
77.47%
-4,47
-2,72
-64.41%
EPS
USD
Released
Forecast
Spread
-400
-300
-33.33%
-189
-300
37%
-136
-185
26.76%
-26,5
-22,0
-20.45%
-5,00
-11,0
54.55%
-5,91
-7,50
21.2%
-2,15
-4,95
56.52%
-0,27
-1,84
85.33%
-1,51
-0,92
-64.13%
Announcement Date30/03/2212/05/2211/08/2207/11/2222/03/2311/05/2309/08/2309/11/2328/03/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AGRX Stock
  4. Calendar Agile Therapeutics, Inc.